Xuetong Shen
Associate Professor
Department of Epigenetics and Molecular Carcinogenesis
MD Anderson Cancer Center
United States of America
Biography
1996 :University of Rochester, Rochester, NY, USA, PHD, Molecular and Cell Biology 1993 :University of Rochester, Rochester, NY, USA, MS, Molecular Biology 1991 :Peking University, CHN, BS, Biophysics
Research Interest
Epigenetics and Molecular Carcinogenesis
Publications
-
Shen J, Peng Y, Wei L, Zhang W, Yang L, Lan L, Kapoor P, Ju Z, Mo Q, Shih IeM, Uray IP, Wu X, Brown PH, Shen X, Mills GB, Peng G. ARID1A Deficiency Impairs the DNA Damage Checkpoint and Sensitizes Cells to PARP Inhibitors. Cancer Discov 5 (7) :752-67, 2015. e-Pub 2015.
-
Wang X, Chu H, Lv M, Zhang Z, Qiu S, Liu H, Shen X, Wang W, Cai G. Structure of the intact ATM/Tel1 kinase. Nat Commun 7:11655, 2016.
-
Guo DC, Duan XY, Regalado ES, Mellor-Crummey L, Kwartler CS, Kim D, Lieberman K, de Vries BB, Pfundt R, Schinzel A, Kotzot D, Shen X, Yang ML, University of Washington Center for Mendelian Genomics, Bamshad MJ, Nickerson DA, Gornik HL, Ganesh SK, Braverman AC, Grange DK, Milewicz DM. Loss-of-Function Mutations in YY1AP1 Lead to Grange Syndrome and a Fibromuscular Dysplasia-Like Vascular Disease. Am J Hum Genet 100 (1) :21-30, 2017
